Skip NavigationSkip to Content

Therapeutic antibodies, vaccines and antibodyomes

  1. Author:
    Dimitrov, D. S.
  2. Author Address

    NCI, Prot Interact Grp, Ctr Canc Res, Nanobiol Program,NIH, Frederick, MD 21701 USA.;Dimitrov, DS, NCI, Prot Interact Grp, Ctr Canc Res, Nanobiol Program,NIH, Frederick, MD 21701 USA.;dimiter.dimitrov@nih.gov
    1. Year: 2010
    2. Date: May-Jun
  1. Journal: Mabs
    1. 2
    2. 3
    3. Pages: 347-356
  2. Type of Article: Article
  3. ISSN: 1942-0862
  1. Abstract:

    The potential for antibodies to act as "magic bullets" for treatment of human disease was recognized a century ago, but its full realization has began to occur only during the last decade. A key to their current success is the ability to make libraries of antibodies/B cells, isolate a single species, and engineer it to be safe, efficacious and of high quality. Despite this progress, major challenges to the effective prevention, diagnosis and treatment of a vast majority of diseases remain. Limited success in the development of effective vaccines against diseases such as AIDS and cancer reflects our incomplete understanding of how antibodies are generated and function. Only a miniscule number of antibodies are characterized out of the universe of antibodies generated by the immune system. Knowledge of antibodyomes the complete sets of antibodies could help solve these and other challenges.

    See More

External Sources

  1. WOS: 000281388200013

Library Notes

  1. Fiscal Year: FY2009-2010
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel